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he synaptotagmins (syts) are a family of membrane
proteins proposed to regulate membrane trafﬁc in
neuronal and nonneuronal cells. In neurons, the
Ca
 
2
 
 
 
-sensing ability of syt I is critical for fusion of docked
synaptic vesicles with the plasma membrane in response to
stimulation. Several putative Ca
 
2
 
 
 
–syt effectors have been
identiﬁed, but in most cases the functional signiﬁcance of
these interactions remains unknown. Here, we have used
recombinant C2 domains derived from the cytoplasmic
domains of syts I–XI to interfere with endogenous syt–effector
T
 
interactions during Ca
 
2
 
 
 
-triggered exocytosis from cracked
PC12 cells. Inhibition was closely correlated with syntaxin–
SNAP-25 and phosphatidylinositol 4,5-bisphosphate (PIP
 
2
 
)–
binding activity. Moreover, we measured the expression levels
of endogenous syts in PC12 cells; the major isoforms are I
and IX, with trace levels of VII. As expected, if syts I and IX
function as Ca
 
2
 
 
 
 sensors, fragments from these isoforms
blocked secretion. These data suggest that syts trigger fusion
via their Ca
 
2
 
 
 
-regulated interactions with t-SNAREs and PIP
 
2
 
,
target molecules known to play critical roles in exocytosis.
 
Introduction
 
The Ca
 
2
 
 
 
-triggered fusion of secretory organelles with the
plasma membrane mediates synaptic transmission and the
release of hormones from neuroendocrine cells. The SNARE
complex is thought to form the core of the membrane fusion
complex (Söllner et al., 1993; Jahn and Südhof, 1999). This
complex is composed of the t-SNAREs syntaxin and SNAP-25
and the v-SNARE synaptobrevin (also known as vesicle-
associated membrane protein). Reconstitution experiments
demonstrate that the SNARE complex can drive slow Ca
 
2
 
 
 
-
independent membrane fusion in vitro (Weber et al., 1998).
However, rapid release of neurotransmitters and hormones
requires additional factors. Current evidence suggests that
the integral membrane protein, synaptotagmin (syt),* may
function as a Ca
 
2
 
 
 
 sensor that triggers fast fusion events
(Augustine, 2001).
Syts represent a gene family with at least 13 members that
are widely distributed in neuronal and nonneuronal tissues
(Perin et al., 1990; Craxton, 2001). Members of this family
have the same overall structure consisting of an NH
 
2
 
-terminal
transmembrane domain and a cytoplasmic COOH-terminal
domain. The cytoplasmic domain contains two regions
called C2 domains (Perin et al., 1990). C2 domains are con-
served motifs found in 
 
 
 
120 genes in the human genome.
The two C2 domains of syt, designated C2A (membrane
proximal C2 domain) and C2B (membrane distal C2 domain)
(Perin et al., 1990), function as Ca
 
2
 
 
 
-binding modules that
mediate Ca
 
2
 
 
 
-dependent interactions with other molecules
(Tucker and Chapman, 2002).
Syt I is the best characterized isoform and is a major
constituent of synaptic vesicles and neuroendocrine secre-
tory granules (Matthew et al., 1981; Perin et al., 1991;
Chapman and Jahn, 1994). Detailed analysis of syt I mutants
indicates that disruption of its Ca
 
2
 
 
 
-sensing properties impairs
evoked exocytosis from nerve terminals (Fernández-Chácon
et al., 2001; Littleton et al., 2001; Mackler et al., 2002;
Robinson et al., 2002), but the mechanism by which
Ca
 
2
 
 
 
–syt I triggers release is not known. In vitro studies
indicate that at 10–200 
 
 
 
M Ca
 
2
 
 
 
, syt I binds anionic
phospholipids (Brose et al., 1992; Bai et al., 2002) and the
t-SNAREs, syntaxin, and SNAP-25 (Chapman et al.,
1995; Schiavo et al., 1997; Gerona et al., 2000). Ca
 
2
 
 
 
 also
triggers the homo- and heterooligomerization of several syt
isoforms (Fukuda and Mikoshiba, 2000; Wu et al., 2003).
These Ca
 
2
 
 
 
-dependent interactions have been proposed to
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couple Ca
 
2
 
 
 
 influx to fusion (Augustine, 2001; Tucker
and Chapman, 2002).
Whereas syt I regulates exocytosis from neurons and neu-
roendocrine cells, the function of other members of the syt
family are less clear. It has become apparent recently that the
Ca
 
2
 
 
 
 sensitivity of release can differ by orders of magnitude
between distinct cell types (Heidelberger et al., 1994; Boll-
mann et al., 2000; Schneggenburger and Neher, 2000).
These findings are consistent with the idea that syts with dis-
tinct Ca
 
2
 
 
 
 sensitivities might determine the Ca
 
2
 
 
 
 require-
ments for fusion (Li et al., 1995; Gerona et al., 2000; Sugita
et al., 2002). Interestingly, some syt isoforms are weak Ca
 
2
 
 
 
sensors, and up-regulation of one of these isoforms, syt IV,
reduces secretion (Littleton et al., 1999; Wang et al., 2001;
but see also Robinson et al., 2002).
Multiple syt isoforms can operate in parallel in at least
some cell types. For example, PC12 cells express high levels
of syts I and IX, and antibodies directed against either iso-
form partially interfere with release (Elferink et al., 1993;
Fukuda et al., 2002a). However, PC12 cells lacking syt I ex-
hibit robust Ca
 
2
 
 
 
-dependent exocytosis (Shoji-Kasai et al.,
1992); thus, syts I and IX appear to function in a redundant
manner. Finally, in mice, 
 
Caenorhabditis elegans
 
, and 
 
Dro-
sophila
 
, some degree of regulated exocytosis persists in syt
I–null mutants (DiAntonio and Schwarz, 1994; Geppert et
al., 1994; Littleton et al., 1994; Jorgensen et al., 1995), sug-
gesting that additional syt isoforms, or other Ca
 
2
 
 
 
-sensing
proteins, also regulate release.
Some of the first evidence that syt I plays a role in secre-
tion came from inhibition experiments using recombinant
fragments and peptides corresponding to regions of syt I
(Bommert et al., 1993; Elferink et al., 1993). To understand
how syt triggers release, we used a panel of recombinant C2
domains derived from several syt isoforms to acutely inhibit
secretion from cracked PC12 cells. We then screened the
biochemical properties of these C2 domains and found that
inhibition of exocytosis was closely related to the ability of
C2 domains to bind three molecules essential for fusion:
phosphatidylinositol 4,5-bisphosphate (PIP
 
2
 
), syntaxin, and
SNAP-25. These findings suggest that syts regulate exocyto-
sis via direct interactions with both target membrane phos-
pholipids and components of the fusion complex.
 
Results
 
Inhibition of Ca
 
2
 
 
 
-triggered catecholamine release 
from PC12 cells by C2A domains derived from 
syt isoforms I–XI
 
We reasoned that C2 domains derived from multiple syt
isoforms would inhibit secretion from cracked PC12 cells
based on their ability to disrupt endogenous syt–effector in-
teractions that are critical for large dense core vesicle
(LDCV) fusion with the plasma membrane (Fig. 1 A).
Since many syt isoforms are likely to function in the same
manner, inhibitory C2 domains would be expected to inter-
act with a common set of effectors, thus providing insight
into the mechanism of syt function during Ca
 
2
 
 
 
-triggered
fusion. To address this, we generated C2A domains from
syts I–XI and measured their ability to inhibit catechola-
 
mine release from cracked PC12 cells using a recently devel-
oped real-time voltammetry assay (Earles et al., 2001). C2A
domains were chosen because of their relative ease of bacte-
rial expression compared with the C2B or tandem C2A-
C2B domains of the syt family. Furthermore, isolated C2
domains engage fewer effectors than the tandem C2 do-
mains, simplifying screens for common effectors. We then
correlated the ability of the C2 domains to inhibit release
with their ability to engage a set of well-characterized syt-
binding partners.
The C2A domains derived from syts I–XI exhibited dis-
tinct abilities to interfere with exocytosis: III, V, VII, and X
were the most effective inhibitors (
 
 
 
35% at 10 
 
 
 
M; Fig. 1
B). This is in agreement with previous reports showing that
C2A-III and C2A-VII inhibit release of 
 
3
 
H-norepinephrine
from PC12 cells (Shin et al., 2002; Sugita et al., 2001, 2002).
Notably, the C2A domains from syts I and IX failed to in-
hibit secretion by 
 
 
 
20%. Syts I and IX are thought to be the
primary Ca
 
2
 
 
 
 sensors for exocytosis in PC12 cells (Fukuda et
al., 2002a; Zhang et al., 2002). However, others have argued
that the inhibitory activity of C2A-III and C2A-VII demon-
strates that these isoforms are the major Ca
 
2
 
 
 
 sensors for exo-
cytosis in PC12 cells (Sugita et al., 2001, 2002). Below, we
provide data that resolve this controversy.
Figure 1. Screening the C2A domains of syt I–IX for inhibition of 
exocytosis. (A) A model of syt function during exocytosis; Ca
2 –syt 
triggers release via interactions with effector molecules. Addition of 
exogenous C2 domains derived from different syt isoforms competes 
with endogenous syt for effector interactions, thereby inhibiting fusion. 
(B) C2A domains derived from syts I–XI exhibit different abilities to 
disrupt catecholamine release from PC12 cells. The indicated C2A 
domain (10  M) was added to the reaction chamber 1 min before 
release was triggered with 100  M CaCl2. Control samples lacking 
recombinant protein (buffer alone) were analyzed in parallel and 
used to calculate the percentage of inhibition. We note that some 
experiments were performed at the lowest [Ca
2 ] at which we could 
reliably measure secretion; in these experiments, the C2A domains 
of syt III and VII exhibited the same inhibitory activity that was 
observed at 100  M Ca
2  (unpublished data). (C) Inhibition of 
catecholamine release by C2A-III and C2A-VII occurs at all times 
during the release process. C2A-I, -III, and -VII (10  M) were added 
at the indicated time (relative to Ca
2  addition). For each timing 
experiment, release profiles were superimposed along with a control 
trace (buffer only).T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
 
 
Syt–effector interactions during fusion |
 
 Tucker et al. 201
 
Further experiments were performed to assess the timing
of inhibition by the inhibitory C2A domains. The inhibi-
tory effects of C2A-III and VII did not require preincuba-
tion with cracked cells; inhibition was observed whether the
C2A domains were added before, concurrently with, or after
the addition of Ca
 
2
 
 
 
 (Fig. 1 C). These data indicate that the
onset of inhibition occurs during a late, postdocking step in
this system, consistent with previous studies of syt function
(Desai et al., 2000; Earles et al., 2001).
 
C2A-mediated inhibition of release correlates with 
PIP
 
2
 
 and t-SNARE–binding activity
 
Ca
 
2
 
 
 
 triggers the penetration of the Ca
 
2
 
 
 
-binding loops of
syt into the surface of lipid bilayers that contain anionic
phospholipids (e.g., phosphatidylserine [PS]), and this inter-
action has been proposed to function as a coupling step in
excitation-secretion coupling (Bai et al., 2002). Whereas PS-
binding activity has been characterized for the isolated C2A
domains of syts I–VIII (Li et al., 1995; Sugita et al., 2002),
little is known concerning the interaction of syts with other
lipids, particularly PIP
 
2
 
, which has been shown to bind syt I
(Schiavo et al., 1996). PIP
 
2
 
 is a plasma membrane lipid that
is essential for exocytosis of LDCVs (Eberhard et al., 1990;
Hay and Martin, 1993; Hay et al., 1995), potentially via its
interactions with syt. Therefore, we screened the C2A do-
mains used in the inhibition studies for PS- and PIP
 
2
 
-bind-
ing activity (Fig. 2, A and C). With the exception of iso-
forms IV, VIII, and XI, the C2A domains of the syt family
bound PS-containing liposomes in response to Ca
 
2
 
 
 
 (Fig. 2
C). The PIP
 
2
 
-binding profile, however, was dramatically dif-
Figure 2. Inhibition of secretion by C2A 
domains is correlated with PIP2-binding activity. 
GST fusions of the indicated C2A isoforms 
(0.13 nmole) were immobilized on glutathione-
Sepharose beads and assayed for 
3H-labeled 
liposome binding in the presence of 2 mM EGTA 
(white bars) or 100  M Ca
2  (black bars) as 
described in Materials and methods. (A) PIP2-
binding properties of C2A from syt I–XI. 
Liposomes were composed of 1.5% PIP2/98.5% 
PC. (B) The extent of inhibition (Fig. 1 B) was 
plotted versus the extent of PIP2-binding activity 
at 100  M Ca
2  (A). Data were fitted by linear 
regression; r
2 values and P values are reported. 
(C) PS-binding properties of C2A from syt I–XI. 
Liposomes were composed of 25% PS/ 75% 
PC. (D) The extent of inhibition (Fig. 1 B) was 
plotted versus the extent of PS-binding activity 
at 100  M Ca
2  (C). Note that C2A-I and -II 
exhibit robust PS-binding activity but fail to 
inhibit release. (E) Kinetic studies of C2A–PS/PC 
liposome interactions. Fluorescence resonance 
energy transfer between native tryptophan 
residue(s) (donor) in C2A and dansyl-PE 
incorporated into liposomes (acceptor; 5% with 
25% PS/70% PC) was used to monitor the time 
course of C2A–PS/PC membrane interactions as 
described previously (Davis et al., 1999). Kinetic 
traces for each C2A (3  M [final]) were obtained 
by rapid mixing with liposomes (11 nM [final]) 
plus Ca
2  (100  M [final]). The observed rates 
(kobs) were determined by fitting the data with 
a single exponential function for C2A-I and 
-III; data for C2A-VII were best fitted by a double 
exponential function. (Inset) kobs is plotted as a 
function of the indicated liposome concentration. 
Note the kobs of the slower component ( ) 
of C2A-VII is not dependent on liposome 
concentration, indicating that it represents 
a conformational change or complex 
rearrangement, such as oligomerization (Fukuda 
and Mikoshiba, 2001; Wu et al., 2003), after 
C2A–liposome complex assembly; only the fast 
component ( ) is considered here. Error bars 
represent that SD from three independent 
experiments. (F) PIP2 enhances the affinity of 
C2A-III and C2A-VII, but not C2A-I, for membranes. Values for koff, kon, and KD of the C2A–liposome interaction were calculated as described 
previously (Davis et al., 1999). C2A-I, -III, and -VII bind to liposomes containing 25% PS (with 70% PC and 5% dansyl-PE) with similar rate 
constants and affinities, whereas C2A-III and -VII exhibit a three- to fourfold lower KD for liposomes containing 1.5% PIP2 and 25% PS (with 
68.5% PC and 5% dansyl-PE).T
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ferent (Fig. 2 A). PIP
 
2
 
-containing liposomes bound C2A-III
and C2A-VII and to a lesser extent C2A-V and C2A-X.
Hence, PIP
 
2
 
–C2A interactions are restricted to fewer syt iso-
forms than is PS-binding activity. However, as detailed be-
low, in some syt isoforms PIP
 
2
 
 binding is mediated by the
C2B domain (see Fig. 6; Schiavo et al., 1996).
PIP
 
2
 
-binding activity and inhibition of catecholamine re-
lease from PC12 cells were well correlated (Fig. 2 B; r
 
2 
 
 
 
0.80). This finding suggests that PIP
 
2
 
-binding C2A domains
disrupt the interaction of endogenous syt with PIP
 
2
 
 to re-
duce LDCV fusion. We also found that PS-binding activity
did not always result in inhibition; PS binding was only
weakly correlated with inhibition (Fig. 2 D; r
 
2 
 
 
 
 0.38). For
example, C2A-I and II failed to inhibit release by 
 
 
 
10% de-
spite the fact that both C2 domains bind PS to the same ex-
tent as the inhibitory C2A domains under the same condi-
tions (e.g., C2A-III and -VII). These results suggest that
inhibitory domains affect release via interactions with PIP
 
2
 
but not PS.
In contrast to the findings above, it was suggested previ-
ously that C2A domains derived from different syt isoforms
inhibit secretion in PC12 cells due to their ability to bind PS
in the presence of Ca
 
2
 
 
 
 (Shin et al., 2002; Sugita et al.,
2002). The lipid-binding assays illustrated in Fig. 2 were per-
formed using single concentrations of C2A, lipid, and Ca
 
2 .
It remained possible, therefore, that at 100  M Ca
2  (the
conditions of our release assays) C2A from syts III and VII
may bind PS more tightly than C2A-I and are therefore more
inhibitory. To address this, we measured the kinetics of bind-
ing of noninhibitory (C2A-I) and inhibitory (C2A-III and
C2A-VII) C2 domains to liposomes composed of 25% PS
and 75% phosphatidylcholine (PC). Binding was monitored
via FRET and resolved in time using a stopped-flow rapid
mixing approach (Davis et al., 1999). As shown in Fig. 2 E,
all three C2A domains bound to PS/PC liposomes with
nearly identical kinetics. From kon and koff, the Kd for all three
domains was found to be virtually identical: 2.2–3.5 nM at
100  M Ca
2  (Fig. 2 F). These data demonstrate that differ-
ences in the abilities of the C2A domains derived from syts I,
III, and VII to inhibit release are not due to differences in
their abilities to bind PS. We observed that C2A-VII also ex-
hibited an additional, slow kinetic component that reflects a
postmembrane-binding rearrangement, which may corre-
spond to membrane-induced oligomerization (Fukuda and
Mikoshiba, 2001; Wu et al., 2003). We also note that these
kinetics data differ somewhat from those in a previous report
using a mutant form of C2A-I (Davis et al., 1999); these dif-
ferences are due to the use of synthetic lipids and wild-type
C2A-I for the experiments shown in Fig. 2 E.
These data raise the question of whether the C2 domains
of syt can sense PIP2 in the presence of the relatively high
levels of PS that are found on the inner leaflet of the plasma
membrane (Breckenridge et al., 1972; Westhead, 1987). To
address this, the kinetics experiments shown in Fig. 2 E were
repeated using liposomes composed of 25% PS plus 1.5%
PIP2. These data are summarized in Fig. 2 F, where it is
apparent that inclusion of PIP2 increased the affinity of
C2A-III and C2A-VII for membranes by three- to fourfold;
C2A-I was unaffected by PIP2 and served as a negative con-
trol. These data establish that, in an environment in which
the anionic lipid is predominantly PS, the properties of at
least some C2 domains are still affected by the presence of
physiological levels of PIP2 (i.e., 1–3%; Tran et al., 1993).
As noted in the Introduction, syt also forms direct con-
tacts with syntaxin and SNAP-25, two components of the
fusion complex. This interaction provides a compelling
connection between the Ca
2  sensor for exocytosis and the
fusion apparatus. We explored the idea that C2A domains
might inhibit release by blocking syt–SNARE interactions
by assaying the ability of C2A from syts I–XI to bind puri-
fied SNAP-25–syntaxin heterodimers (Fig. 3). Isoforms III,
V, VII, and X exhibited robust Ca
2 -promoted binding ac-
tivity, whereas binding was much weaker or devoid for the
other isoforms (Fig. 3 B). The correlation between the abil-
Figure 3. Inhibitory C2A domains bind t-SNAREs. 
(A) t-SNARE–binding profiles of the C2A domains 
derived from syts I–XI. Immobilized GST–C2A fusions 
(20  g in 150  l HBS plus 0.5% Triton X-100) and 5 
 M t-SNARE hetero-dimer were incubated in 2 mM 
EGTA (  Ca
2 ) or 1 mM CaCl2 (  Ca
2 ). 20% of 
bound protein and 3% of total t-SNARE was subjected 
to SDS-PAGE and stained with Coomassie blue. 
(B) The C2A domains exhibit different degrees of Ca
2 -
dependent t-SNARE binding. The t-SNARE–binding 
assay shown in A was quantified by densitometry, 
and relative optical density (O.D.) was plotted in the 
presence (black bars) or absence (white bars) of Ca
2 . 
(C) Inhibition of catecholamine release by C2A domains 
correlates with t-SNARE binding. The percentage of 
inhibition was plotted as a function of Ca
2 -dependent 
t-SNARE binding.T
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ity of C2A domains to bind neuronal t-SNAREs in the
presence of Ca
2  and to inhibit release was striking (Fig. 3
C; r
2   0.93); the extent of inhibition by a C2A domain is
directly proportional to its ability to engage t-SNAREs.
These results suggest that inhibitory C2A domains inhibit
catecholamine release from PC12 cells by disruption of en-
dogenous syt–SNARE interactions and by perturbing syt–
PIP2 interactions.
Expression levels of syt isoforms in PC12 cells
The experiments described above provide strong evidence
that C2A domains inhibit regulated secretion in PC12 cells
by binding PIP2 and/or t-SNAREs, presumably by blocking
endogenous syt–PIP2–t-SNARE interactions to disrupt a
late step in the fusion reaction (Fig. 1 A). Next, we asked
which isoforms of syt are being interfered with by the exoge-
nous C2 domains characterized above. There has been con-
siderable controversy regarding which syt isoforms are ex-
pressed in PC12 cells. Zhang et al. (2002) performed
immunoblot studies using antibodies directed against syt
isoforms I–XIII. Syt isoforms I, IV, and IX were the only
isoforms that were detected in PC12 cells. All three isoforms
have been localized to LDCVs (Wang et al., 2001; Fukuda
et al., 2002a, 2003). Syt I and IX were expressed at much
higher levels than syt IV and appear to function as redun-
dant Ca
2  sensors for LDCV fusion (Shoji-Kasai et al.,
1992; Fukuda et al., 2002a). In contrast, others have pro-
posed that syts III and VII serve as the major Ca
2  sensors in
PC12 cells (Sugita et al., 2001, 2002; Shin et al., 2002). To
resolve this controversy, we generated antibodies against syts
III, VII, and IX and quantified the abundance of each iso-
form in PC12 cells.
Peptides corresponding to nonconserved segments of syt
III, VII, and IX were used to raise isoform-specific antibod-
ies (Fig. 4 A). In the case of syt VII, the peptide corre-
sponded to a region present in all predicted splice variants
(Sugita et al., 2001). Antibodies to syt IV, which was previ-
ously reported to be expressed at low levels in PC12 cells
(Zhang et al., 2002), were also generated. After affinity pu-
rification, antibodies were screened for specificity. mAb
Figure 4. Syts I and IX are the major syt isoforms in 
PC12 cells. (A) Peptides corresponding to the indicated 
regions of syts III, IV, VII, and IX were used to produce 
polyclonal antibodies as described in Materials and methods. 
(B) Specificity of the anti-syt ( -syt) antibodies. 100 ng of 
the indicated GST–syt fragments lacking the C2B domain 
( I, III, IV, and VII) or composed of only the cytoplasmic 
domain ( IX) were subjected to SDS-PAGE, transferred to 
nitrocellulose, and probed with the indicated antibody. 
Truncated syt fragments were used due to their relative ease 
of expression and isolation compared with full-length syts. 
Recombinant protein preparations often contained multiple 
proteolytic fragments as a result of bacterial expression; 
quantification of recombinant standards was based on the abundance of the band corresponding to the molecular weight of the intact protein. 
Each of the antibodies is specific for the syt it is raised against. For  I, mAb 41.1 was used (Chapman and Jahn, 1994). (C) Syt expression levels 
in PC12 cells. The indicated amounts of recombinant standards and postnuclear PC12 cell membranes (total protein) were subjected to 
SDS-PAGE and immunoblot analysis using the indicated antibodies. (D) Syt VII is a low abundance Ca
2  sensor in PC12 cells. Immunoblots 
for syts III, IV, and VII were performed as described in C with reduced amounts of standards and increased amounts of cell membranes as 
indicated. (E) Blots shown in C and D were quantified by densitometry and plotted as a percentage of total protein from membranes. Since 
multiple bands were detected for each isoform expressed, quantitation was based on total immunoreactivity from cell extracts by summing 
the density of all bands. (F) Anti–syt-III and -VII antibodies detect syt III and VII expressed in fibroblasts. HEK cells were transfected with 
expression constructs (pCI-neo; Promega) for syt isoforms I, III, or VII ( ), or empty vector ( ), and probed with their respective antibody.T
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41.1 was used to detect syt I (Chapman and Jahn, 1994).
As shown in Fig. 4 B, all five antibodies recognized only
the appropriate syt isoform. The antibodies were then used
to carry out quantitative immunoblot analysis of PC12 cell
membranes using recombinant protein standards (Fig. 4
C). Syts I and IX were readily detected and accounted for
 0.26 and 0.15%, respectively, of the total membrane
protein (Fig. 4, C and E). The ratio of syt I to syt IX
( 1.6) is similar to the value ( 1.3) reported previously
(Zhang et al., 2002). Syts III, IV, and VII were not de-
tected at the level of sensitivity adequate for isoforms I and
IX (Fig. 4 C). In an effort to detect these isoforms, we de-
creased the levels of the standards loaded onto the blots,
and we increased the level of PC12 cell membranes (Fig. 4
D). Under these conditions, the syt VII antibody yielded
bands at  45, 40, and 26 kD. Together, these bands repre-
sent  0.007% of the total protein (Fig. 4 E) and is 37
times less abundant that syt I. The multiple syt VII bands
are likely to reflect splice variants (Sugita et al., 2001) or
degradation products. A similar banding pattern was seen
in HEK cells transfected with full-length syt VII, although
the intensity of the 26-kD band was significantly reduced
relative to the higher molecular weight bands (Fig. 4 F). In
brain extracts, higher molecular weight bands ( 76 kD)
and a virtually identical banding pattern to that reported
by Sugita et al. (2001) were observed (unpublished data),
indicating that these antibodies recognize the same anti-
gens. A faint band at  26 kD became apparent in the high
sensitivity syt III blots, but bands expected for the full-
length protein were not observed (Fig. 4 D). It is not clear
whether the 26-kD band is the result of nonspecific bind-
ing, cross reactivity, or a degradation product of the full-
length protein. Transfection of syt III in HEK cells gave
rise to a single band at  80 kD (Fig. 4 F), consistent with a
previous report (Fukuda et al., 1999). Hence, this antibody
is able to recognize syt III expressed in mammalian cells.
On some blots, a faint syt IV band was present, but the
level of expression was too low to quantify.
Given these data, syts I and IX are likely to be the primary
syts in PC12 cells. It cannot be ruled out that syt VII may
play a role in Ca
2 -dependent LDCV exocytosis. At present,
it has not been possible to localize native syt VII using cur-
rently available antibodies. In transiently transfected PC12
cells, syt VII–GFP fusion proteins were initially reported to
localize to the cell periphery, and it was suggested that they
were targeted to the plasma membrane (Sugita et al., 2001).
In a later study, using stable PC12 cell lines, syt VII-GFP
was shown to colocalize with syt I and trans Golgi markers
(Fukuda et al., 2002b). Thus, syt VII appears to be on an or-
ganelle that participates in Ca
2 -triggered exocytosis. How-
ever, our immunoblot data indicate that this isoform is at
least 30 times less abundant that syt I. Furthermore,  50%
of the syt VII detected in our blots is truncated and may lack
an intact cytoplasmic domain (Fig. 4, D and E).
In syt I and IX, critical effector interactions require 
tandem C2 domains or are localized to the C2B domain
If syts I and IX are the primary Ca
2  sensors in PC12 cells,
why do the C2A domains derived from these isoforms fail to
inhibit catecholamine release? One possible explanation is
that syt–effector interactions important for exocytosis are lo-
calized to either the C2B domain or to the tandem C2 do-
mains of syt I and IX. Indeed, in syt I the C2B domain but
not the C2A domain binds PIP2 (Schiavo et al., 1996) and
inhibits secretion from PC12 cells (Desai et al., 2000). Fur-
thermore, in syt I both C2A and C2B are needed for high af-
finity t-SNARE–binding activity (Chapman et al., 1996;
Davis et al., 1999; Gerona et al., 2000). In the following
paragraphs, we further explore this possibility.
Recombinant C2B-I copurifies with a bacterial contami-
nant that appears to be RNA (Ubach et al., 2001; Wu et al.,
2003; unpublished data). Others have reported that removal
of this contaminant disrupts inhibition mediated by C2B-I
(Sugita et al., 2001; Shin et al., 2003). For our studies, re-
combinant proteins including t-SNAREs and C2 domains
were treated with nucleases and high salt buffers, which
completely remove bacterial contaminants. We found that
contaminant-free C2B-I retained inhibitory activity (Fig. 5;
Desai et al., 2000). Thus, inhibition of secretion is not an
artifact due to the presence of the contaminant.
If syts I and IX are the major Ca
2  sensors for LDCV exo-
cytosis in PC12 cells, one would expect that their cytoplas-
mic domains (C2A-C2B) would interfere with endogenous
syt I/IX–effector interactions and block release. This was in-
deed the case: the cytoplasmic domains of syts I and IX (10
 M) inhibited exocytosis by 61 and 56%, respectively (Fig.
5). As in the case of syt I, most of the inhibitory activity of
syt IX mapped to the C2B domain; again, C2A-I and -IX
were poor inhibitors. We next investigated whether the inhi-
bition of release mediated by fragments of syts I and IX was
correlated with PS, PIP2, and/or t-SNARE–binding activity.
The isolated C2B domains of both syt I and IX exhibit lit-
tle PS-binding activity (Fig. 6 A; note that C2B-I binds PS
tightly when tethered to C2A [Bai et al., 2002]). Thus, there
is no correlation between PS-binding activity and inhibition
of catecholamine release by the C2 domains from syts I and
IX (Fig. 6 B; r
2   0.02). In contrast, there is a clear correla-
tion between the ability of fragments of syts I and IX to bind
PIP2 and to inhibit catecholamine release (Fig. 6, C and D;
r
2   0.93).
We next determined whether the ability of syts I and IX
fragments to block release was also correlated with their abil-
ity to bind t-SNAREs. In a GST pull-down assay, the C2B
and the C2A-C2B domains of syts I and IX exhibited strong
binding to syntaxin–SNAP-25 t-SNARE heterodimers (Fig.
7, A and B). Consistent with previous reports, GST-C2A ex-
hibited little t-SNARE–binding activity (Chapman et al.,
1996; Davis et al., 1999). There was a strong correlation be-
Figure 5. The C2B and C2A-C2B 
domains from syt I and syt IX inhibit 
exocytosis. C2A, C2B, and C2A-C2B 
domains (10  M) of syt isoforms I and IX 
were assayed for their ability to inhibit 
exocytosis as described in Fig. 1 B.T
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tween t-SNARE–binding activity and inhibition of secretion
by the syts I and IX fragments (Fig. 7 C; r
2   0.78). These
data further support a model in which syt–SNARE and syt–
PIP2 interactions are essential steps in Ca
2 -triggered exocy-
tosis. Furthermore, these studies establish the idea that the
biochemical activity of a given C2 domain cannot be pre-
dicted by its position in a parent polypeptide. In some cases,
an activity that is localized to the first C2 domain (C2A) in
one isoform might only be manifest in the second C2 do-
main (C2B) of another isoform.
Several studies concluded that tandem C2 domains are
needed for syt I to efficiently bind t-SNAREs (Chapman et
al., 1995, 1996; Davis et al., 1999; Gerona et al., 2000;
Earles et al., 2001). However, in the GST pull-down exper-
iment presented in Fig. 7 A, the isolated C2B domain of syt
I bound the t-SNARE complex nearly as effectively as C2A-
C2B (Fig. 7, A and B). Thus, it appears that either the GST
moiety, or the immobilization of proteins onto beads, can
affect interactions with SNAREs. Therefore, we tested the
ability of the C2 domains derived from syts I and IX to
bind t-SNAREs using a solution-based binding assay. Solu-
ble syt fragments were incubated with soluble t-SNAREs,
and t-SNARE complexes were immunoprecipitated using
an antibody directed against syntaxin (Fig. 7, D and E).
C2A-C2B from syt I and IX engaged t-SNAREs much
more effectively than did the isolated C2 domains. The
C2B domains of syts I and IX exhibited a low level of
SNARE-binding activity; binding of the C2A domains
could not be detected in this assay system (Fig. 7). For com-
parison, we tested the ability of the C2A domains from syts
III and VII, which again inhibit catecholamine release, to
engage SNAREs using this assay system. In contrast to
C2A-I and C2A-IX, both C2A-III and C2A-VII exhibited
significant levels of t-SNARE–binding activity (Fig. 7, D
and E). These data further support the idea that inhibitory
C2 domains interfere with secretion by interacting with
t-SNAREs (Fig. 7 F; r
2   0.72).
Figure 6. PIP2-binding activity and inhibition of exocytosis are 
correlated and localized to the C2B domains of syts I and IX. (A) PS-
binding activity of the indicated syt I/IX constructs was assayed as 
described in the legend to Fig. 2 C. (B) PS-binding activity does not 
correlate with inhibition of secretion. The percentage of inhibition 
of catecholamine release (Fig. 5) was plotted as a function of Ca
2 -
dependent PS/PC liposome-binding activity and fitted by linear 
regression. For syts I and IX, PS binding is not necessary for inhibition 
since the C2B domains bind PS weakly yet inhibit release. (C) PIP2-
binding activity of the indicated syt I/IX constructs was assayed as 
described in the legend to Fig. 2 A. (D) PIP2 binding is correlated 
with inhibition of secretion. The percentage of inhibition (Fig. 5) 
was plotted as a function of Ca
2 -dependent PIP2 binding (C) and 
fitted by linear regression.
Figure 7. Inhibitory fragments of syt I and IX bind t-SNAREs. 
(A) GST-C2A, -C2B, or -C2A-C2B (3  M) from syts I and IX was 
immobilized on beads and assayed for t-SNARE heterodimer- (5  M) 
binding activity, as described in Materials and methods, in the presence 
of EGTA (2 mM) or Ca
2  (1 mM). Proteins were visualized by staining 
with Coomassie blue. (B) Quantitation of t-SNARE–binding activity 
was determined by densitometry of bands shown in A. EGTA, white 
bars; Ca
2 , black bars. (C) Inhibition of secretion correlates with 
t-SNARE–binding activity. The percentage of inhibition (Fig. 5) is 
plotted as a function of Ca
2 -dependent t-SNARE–binding activity 
(B). (D) Coimmunoprecipitation of syt I and IX with t-SNAREs. 
Soluble syt fragments (2  M) were incubated with soluble t-SNARE 
heterodimer (2  M) in 2 mM EGTA or 1 mM Ca
2  for 1 h. Syntaxin 
was then immunoprecipitated by adding mAb HPC-1 and protein
G–Sepharose. Immunoprecipitates were subjected to SDS-PAGE; 
gels were stained with Coomassie blue. (E) Quantitation of t-SNARE–
binding assayed by coimmunoprecipitation. Quantitation was 
performed by densitometry as described in B. (F) The percentage 
of inhibition (Fig. 5) was plotted as a function of Ca
2 -dependent 
t-SNARE binding as determined by coimmunoprecipitation in E.T
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We reiterate that the two assays used to monitor syt–
SNARE interactions yield differences in the extent and Ca
2 
dependence of binding, particularly in the case of C2B and
C2A-C2B from syt I and IX (Figs. 3 and 7). These differ-
ences might explain some of the apparent discrepancies that
arose from previous studies in which binding of syt I to
SNAREs was either Ca
2  dependent (Chapman et al., 1995;
Davis et al., 1999) or largely Ca
2  independent (Schiavo et
al., 1997). In the former study, a coimmunoprecipitation
approach was used, and in the latter study syt I fragments
were immobilized on beads as GST fusion proteins. It is im-
portant to note that native syt I–SNARE interactions are
likely to be Ca
2  dependent in vivo, since cross-linking ex-
periments of endogenous syt to SNAP-25 in semiintact
PC12 cells is strongly dependent on increases in Ca
2 
(Zhang et al., 2002). Furthermore, syt and t-SNAREs coim-
munoprecipitate from brain extracts in a Ca
2 -promoted
manner (Chapman et al., 1995).
Discussion
The data reported here are consistent with the hypothesis
that members of the syt family confer Ca
2  sensitivity to
membrane fusion through Ca
2 -dependent interactions with
PIP2 and t-SNAREs. These effector molecules are localized to
the target membrane where they play a critical role in exocy-
tosis (Jahn and Südhof, 1999; Holz et al., 2000). PIP2 is
thought to function via recruitment of proteins to their sites
of action (Cremona and De Camilli, 2001). Our results are
consistent with the idea that PIP2 recruits the cytoplasmic
domain of syt toward the target membrane during exocytosis.
This trans interaction might contribute to the ensemble of
vesicle/target membrane interactions that pull the bilayers to-
gether to ultimately mediate fusion. Syt–PIP2 interactions
could also enhance binding of syt to t-SNAREs. We note
that in our studies, all of the C2 domains that bound to
t-SNAREs also bound to PIP2 and vice versa (r
2 values range
from 0.651–0.786, depending on the assay system used). It is
possible that C2 domains evolved to recognize both effectors
in a mutually dependent way (detailed below).
Syt I and IX are the major isoforms in PC12 cells, and
both isoforms require relatively high levels of Ca
2  ([Ca
2 ]1/2
 100  M) to bind t-SNAREs (Chapman et al., 1995;
unpublished data). This value is well above the [Ca
2 ]1/2
for catecholamine release from these cells ( 1–20   M;
Klenchin et al., 1998; Earles et al., 2001), raising the con-
cern that syt–SNARE interactions may not occur at physio-
logically relevant Ca
2  concentrations in situ. However, the
affinity of syt for Ca
2  is markedly enhanced by anionic lip-
ids (Brose et al., 1992), indicating that syt–SNARE interac-
tions may occur at lower Ca
2  concentrations in the pres-
ence of membranes. Consistent with this idea, syt appears to
be able to simultaneously interact with both SNAREs and
membranes (Davis et al., 1999). Furthermore, native syt I
cross-links to SNAP-25 in PC12 cell membrane fragments
in a Ca
2 -dependent manner. Cross-linking was largely
complete at 10  M Ca
2 , perhaps owing to the presence of
lipid bilayers (Zhang et al., 2002). We have attempted to di-
rectly measure anionic lipid induced shifts in the Ca
2  re-
quirements for syt–t-SNARE–binding activity but have
been hampered by the formation of large aggregates (unpub-
lished data). Thus, in our biochemical assays we used high
[Ca
2 ] in order to drive efficient syt–SNARE interactions.
In a recent report, it was proposed that Sr
2  triggers exocy-
tosis without activating syt I–t-SNARE interactions (Shin et
al., 2003). However, other studies indicate that Sr
2  is able
to promote syt–t-SNARE interactions (Chapman et al.,
1995; unpublished data).
These data might provide an explanation for the correla-
tion between the ability of the C2 domains characterized
here to bind to both t-SNAREs and PIP2. In this model,
PIP2 is the relevant lipid that increases the affinity of syt for
Ca
2  such that syt can engage t-SNAREs at physiological
levels of Ca
2 . Previous studies indicate that Ca
2 -enhanced
binding of syt to t-SNAREs regulates SNARE complex as-
sembly or function (Littleton et al., 2001). Indeed, the
SNARE complex does not appear to assemble until arrival of
the Ca
2  signal in permeabilized PC12 cells (Chen et al.,
1999). Furthermore, mutations in Drosophila syt I are asso-
ciated with a loss of SDS-resistant SNARE complexes (Lit-
tleton et al., 2001), further supporting the idea that syt I is
required for the assembly of stable SNARE complexes.
A recent study using mutant versions of C2A-I and C2A-
VII indicated that inhibition of catecholamine release from
cracked PC12 cells was correlated with the Ca
2  require-
ments for binding to PS (Shin et al., 2002); C2A domains
with high apparent Ca
2  affinities inhibited release, whereas
those with lower affinities did not. This led the authors to
suggest that syt functions during exocytosis by interacting
with PS rather than with SNARE proteins. However, in
these experiments C2 domains with relatively low apparent
affinities for Ca
2  did not become inhibitory at Ca
2  con-
centrations that were sufficient to drive efficient binding to
PS (Shin et al., 2002), arguing that C2A–PS interactions
cannot mediate inhibition. Also, in our experiments the
Ca
2 -triggered PS-binding activity of all of the C2 domains
was saturated with Ca
2 , yet some PS-binding C2 domains
failed to inhibit release (Fig. 1 B). Moreover, we found that
C2A-I, a noninhibitory domain, and C2A-III and -VII,
which are both potent inhibitors of release, bind PS-contain-
ing liposomes to the same extent, and with the same dissoci-
ation constants, at Ca
2  concentrations identical to those
used in our secretion assays (Fig. 2, E and F). These data
clearly demonstrate that PS-binding activity is not sufficient
to block release under the conditions of our assay system. Fi-
nally, isolated C2B domains from syts I and IX lack strong
PS-binding activity (Fig. 6 A) yet inhibit catecholamine re-
lease from PC12 cells (Fig. 5). In summary, PS-binding ac-
tivity is neither necessary nor sufficient to block release.
It is possible that higher concentrations of PS-binding C2
domains could block exocytosis in our assay system. How-
ever, we note that a 100-nm liposome that contains 25% PS
can bind  225 syt molecules (Bai and Chapman, 2003). PS
is a ubiquitous and abundant constituent of synaptosomal
membranes (7–18 mol%; Breckenridge et al., 1972; West-
head, 1987). Therefore, PC12 cells ( 10  m in diameter)
harbor a large number of C2 domain–binding sites, making
them difficult to saturate without having nonspecific effects
on other interactions within cracked cells. In contrast, PIP2
is present at  10-fold lower concentrations in cellular mem-T
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branes (Tran et al., 1993), and we estimate that in our re-
lease assays t-SNAREs are present at sub  M concentrations
( 0.4  M SNAP-25 and  0.06  M syntaxin; data unpub-
lished). Thus, the levels of free PIP2 and t-SNAREs are likely
to be strongly affected by addition of  M concentrations of
recombinant C2 domains.
What then is the in vivo function of the noninhibitory
PS-binding C2A domains? Our quantitative immunoblots
demonstrate that syts I and IX are the major Ca
2  sensors in
PC12 cells (Fig. 4), yet their isolated C2A domains fail to
inhibit release. The first clue as to the function of C2A-I was
provided by genetic studies in Drosophila. A mutant allele,
AD1, harbors a single point mutation that truncates the pro-
tein after the C2A domain (DiAntonio and Schwarz, 1994).
The synaptic physiology of AD1 flies is distinct from wild-
type or syt-null flies (DiAntonio and Schwarz, 1994; Little-
ton et al., 1994). AD1 exhibits some degree of synchronous
release that is absent from null mutants (Yoshihara and Lit-
tleton, 2002). These data suggest that the role of C2A is to
accelerate fusion. Other groups have mutated the C2A do-
main, but a consensus as to the effects of these mutations has
not been reached (Fernández-Chácon et al., 2001, 2002;
Robinson et al., 2002).
In our acute disruption experiments, inhibition of secre-
tion could involve blockade of additional syt–effector inter-
actions. For example, the ability of C2B-I to inhibit secre-
tion from cracked cells is likely to also involve perturbation
of native syt oligomerization (Desai et al., 2000; Littleton et
al., 2001). This interpretation was recently called into ques-
tion by data showing that recombinant C2B-I contains
tightly bound bacterial contaminants. It was suggested that
removal of the contaminant abolishes the ability of this do-
main to oligomerize in response to Ca
2  (Ubach et al.,
2001); we have confirmed this finding. However, using EM
to visualize syt bound to lipid bilayers that contain anionic
phospholipids, we observed that membranes restore Ca
2 -
triggered oligomerization activity (Wu et al., 2003). A future
challenge will be do develop quantitative assays to determine
whether there is a correlation between oligomerization activ-
ity and inhibition of secretion by C2 domains.
Unexpected differences between syt isoforms are begin-
ning to emerge. For example, some effectors that bind to the
C2B of isoform I (e.g., PIP2) can bind to the C2A domain of
a different isoform (e.g., syt VII). Thus, syts are biochemi-
cally more complex than initially appreciated. It is not clear
why effector interactions are shuffled between tandem C2
domains, but these findings should be taken into account
when single C2 domains are used for perturbation studies.
We note that in several reports, the ability of a syt C2 do-
main to inhibit fusion has been interpreted as evidence for
its function in the pathway under study (Sugita et al., 2001,
2002). For example, it has been argued that syt III is a major
Ca
2  sensor in PC12 cells because the C2A domain derived
from this isoform is potent inhibitor of release (Sugita et al.,
2002). However, we could not detect any syt III in PC12
cells (Fig. 4). This is not unexpected: whereas the complete
cytoplasmic domains of syts that regulate a given fusion step
should inhibit secretion, fragments of irrelevant syt isoforms
or even other molecules can also block secretion if they are
able to bind the targets of the endogenous syt isoforms.
In summary, our data support a model in which syt trig-
gers LDCV fusion in PC12 cells by interacting with PIP2
and t-SNAREs, two effector molecules that are localized to
the target membrane. We propose that these interactions fa-
cilitate fusion by pulling the vesicle and target membranes
together to facilitate SNARE complex assembly.
Materials and methods
Recombinant proteins
cDNA encoding rat syt I (Perin et al., 1990), III (Mizuta et al., 1994), and IV
(Vician et al., 1995) was provided by T.C. Südhof (University of Texas
Southwestern Medical Institute, Dallas, TX), S. Seino (Chiba University,
Chiba, Japan), and H. Herschman (University of California, Los Angeles,
Los Angeles, CA), respectively. cDNA encoding mouse syts II and V–XI
(Fukuda et al., 1999) was provided by M. Fukuda (Institute of Physical and
Chemical Research, Saitama, Japan). The C2A, C2B, and C2A-C2B do-
mains of syt I (the G374 form) and the C2A domain of syt III were prepared
as described previously (Littleton et al., 1999; Desai et al., 2000; Earles et
al., 2001). Syt fragments were subcloned into pGEX 2T-1 or 4T-1 (Amer-
sham Biosciences) as described previously (Chapman et al., 1996). The aa
residues encoding the C2A-C2B and C2A domains of each isoform are as
follows: I, 96–421, 96–265; II, 139–423, 139–265; III, 290–569, 290–421;
IV, 152–425, 152–278; V, 218–491, 218–349; VI, 143–426, 143–273; VII,
134–403, 134–262; VIII, 97–395, 97–238; IX, 104–386, 104–235; X, 223–
501, 223–360; and XI, 150–430, 150–286. Syts lacking the C2B domain
were prepared as follows: I, 1–265; II, 1–267; III, 1–423; IV, 1–280; V,
1–349; VI, 1–273; VII, 1–260; VIII, 1–234; IX, 1–232; X, 1–357; and XI,
1–283. Amino acid residues 215–386 encode the C2B domain of syt IX.
All recombinant constructs were confirmed by DNA sequencing and ex-
pressed as GST fusion proteins. Proteins were purified by affinity chroma-
tography with glutathione Sepharose 4B (Amersham Biosciences) and
washed with nucleases and high salt buffer to remove bacterial contami-
nants as described in Wu et al. (2003). Soluble syt fragments were pre-
pared by thrombin cleavage (Chapman et al., 1996).
The pTW34 construct for expression of the t-SNARE heterodimer com-
posed of mouse his6–SNAP-25 and rat syntaxin 1a was provided by T. We-
ber (Mount Sinai School of Medicine, New York, NY) and purified by
NiNTA chromatography (Weber et al., 1998; Parlati et al., 1999).
Binding assays
All protein–protein interactions were performed in 150  l of HBS (50 mM
Hepes-NaOH, 100 mM NaCl, pH 7.4) with 0.5% Triton X-100 plus 2 mM
EGTA or 1 mM CaCl2. For GST pull-down assays, samples were incubated
for 1 h at 4 C followed by three washes with binding buffer. For immuno-
precipitation studies, soluble syt (C2A-C2B) was incubated with t-SNARE
heterodimer plus 1 mg/ml BSA for 1 h at 4 C. Complexes were immuno-
precipitated using an antisyntaxin mAb (7.5  l HPC-1; provided by R. Jahn
[Max Planck Institute for Biophysical Chemistry, Goettingen, Germany])
and 25  l of a 50% slurry of protein G–Sepharose fast flow (Amersham
Biosciences) as described (Chapman et al., 1995). Immunoprecipitates
were washed three times in binding buffer, solubilized in SDS sample
buffer, and subjected to SDS-PAGE; proteins were visualized by staining
with Coomassie blue.
Radiolabeled liposome-binding assays were performed as described in
Davis et al. (1999). L-3-phophatidyl(N-methyl-
3H)choline-1,2-dipalmitoyl
was purchased from Amersham Biosciences. Error bars represent the SD
from three separate determinations.
Real-time secretion assays
Catecholamine release from cracked PC12 cells was monitored using ro-
tating disc electrode voltammetry was as described (Earles et al., 2001).
Cumulative release was determined by measuring the amplitude of the re-
lease profile 80 s after the addition of 100  M Ca
2 . For each experiment,
SEM is shown for three to five independent determinations.
Antibody generation and quantitative immunoblot analysis
Peptides corresponding to nonconserved regions of syt III (residues 41–52;
sequence: C-IRGYPRGPDADI), IV (residues 102–112; sequence: C-NGN-
FPKTNPKA-amide), VII (residues 86–96; sequence: C-PGQTPHDESDR-
amide), and IX (residues 375–386; sequence: C-RPPDRARPIPAP) were
synthesized, conjugated to keyhole limpet hemocyanin using a Pierce
Chemical Co. KLH Conjugation kit, and used to immunize rabbits. EachT
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peptide was generated with an NH2-terminal cys residue, which was used
to couple it to a matrix for affinity purification using a Pierce Chemical Co.
Sulfolink Kit; immobilization and purification were performed according
to the manufacturers instructions.
Quantitative immunoblot analysis of syt expression was performed on
postnuclear membranes isolated from cultured PC12 cells. Membranes
were prepared by incubating cells in hypotonic buffer (10 mM Tris-HCl, pH
7.0, 2 mM EDTA, 1 mM phenylmethanesulfonyl fluoride, 1  g/ml pepstatin
A, 1  g/ml leupeptin, and 1  g/ml aprotinin) for 20 min at 4 C followed by
homogenization (30 strokes, Dounce glass/glass). A postnuclear supernatant
was prepared by centrifugation at 400 g for 2 min. Membranes were col-
lected by centrifugation at 21,000 g for 15 min and solubilized in 1% SDS.
Protein concentrations were determined by BCA (Pierce Chemical Co.).
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